Ledger.Open graph →
SEC Form D · Amendment · filed January 27, 2020

Immuneering Corp

Offering
$20.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Robert J. Carpenter · Cambridge, MADirectorBenjamin J. Zeskind · Cambridge, MAExec · DirectorJoseph J. Kekst · Cambridge, MADirectorDon Seymour · Grand Cayman, Cayman IslandsDirectorKevin Phillips · Grand Cayman, Cayman IslandsExec · DirectorAdib Mattar · Al Maryah Island, Abu Dhabi, C0DirectorKevin M. Kokko · New York, NYExec · DirectorJoseph J. Kekst · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗